Logo
x

Search category

Subscribe Now

Palvella Therapeutics

Palvella Therapeutics Expands Partnership with Ligand Pharmaceuticals to Accelerate P-III development of Qtorin Rapamycin

Palvella Therapeutics Expands Partnership with Ligand Pharmaceuticals to Accelerate P-III development of Qtorin Rapamycin

  • December 5, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.